Structural and functional responses of river biofilm communities to the nonsteroidal anti-inflammatory diclofenac

Environmental Toxicology and Chemistry

Volumn 26, Issue 4, 2007, Pages 573-582

  Lawrence, John R ^a   Swerhone, George D W ^a   Topp, Edward ^b   Korber, Darren R ^c   Neu, Thomas R ^d   Wassenaar, Leonard I ^a  

^a ENVIRONMENT CANADA   (Canada)

^b AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

Author keywords

Biofilms; Degradation; Diclofenac; Pharmaceuticals; Protozoans

Indexed keywords

BIODEGRADATION; BIOMASS; DENATURATION; DNA; DRUG PRODUCTS; NUTRIENTS; PROTOZOA; SURFACE WATERS;

DICLOFENAC; EXOPOLYSACCHARIDE; GEL ELECTROPHORESIS;

BIOFILMS;

BACTERIAL DNA; CARBON; DICLOFENAC; EXOPOLYSACCHARIDE; GLYCOCONJUGATE; ISOTOPE; NONSTEROID ANTIINFLAMMATORY AGENT; RIVER WATER; SURFACE WATER;

BIOFILM; COMMUNITY STRUCTURE; DRUG; FUNCTIONAL RESPONSE; MICROBIAL COMMUNITY; ORGANIC COMPOUND; POLLUTION EXPOSURE; PROTOZOAN; RIVER POLLUTION; RIVER WATER;

ALGA; ARTICLE; BACTERIAL FLORA; BIOFILM; BIOMASS; CYANOBACTERIUM; DENATURING GRADIENT GEL ELECTROPHORESIS; FLUORESCENCE IN SITU HYBRIDIZATION; METAZOON; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROTOZOON; SEASONAL VARIATION;

ALGAE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACTERIA; BIOFILMS; CARBON RADIOISOTOPES; CYANOBACTERIA; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROSCOPY, CONFOCAL; RIVERS; SEASONS;

EURASIA; EUROPE; NORTH AMERICA;

ALGAE; BACTERIA (MICROORGANISMS); CYANOBACTERIA; PROTOZOA;

EID: 34247528873     PISSN: 07307268     EISSN: None     Source Type: Journal    
DOI: 10.1897/06-340R.1     Document Type: Article

References (38)

1. Kolpin D, Furlong E, Meyer M, Thurman E, Zaugg S, Barber L, Buxton H. 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. stream, 1999-2000: A national reconnaissance. Environ Sci Technol 36:1202-1211.
2. Lissemore L, Hao C, Yang P, Sibley PK, Mabury S, Solomon KR. 2006. An exposure assessment for selected pharmaceuticals within a watershed in Southern Ontario. Chemosphere 64:717-729.
3. Metcalfe CD, Koenig BG, Bennie DT, Servos M, Ternes TA. 2003. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ Toxicol Chem 22: 2872-2880.
4. Ternes TA. 2001. Pharmaceuticals and metabolites as contaminants of the aquatic environment. In Daughton CG, Jones-Lepp TL, eds, Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues. ACS Symposium Series. American Chemical Society, Washington, DC, pp 23-34.
5. Halling-Sørensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten Lützhoff HC, Jorgensen SE. 1998. Occurrence, fate, and effects of pharmaceutical substances in the environment - A review. Chemosphere 36:357-393.
6. Buser HR, Poiger T, Muller MD. 1998. Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: Rapid photodegradation in a lake. Environ Sci Technol 32:3449-3456.
7. Farre M, Ferrer I, Ginebreda A, Figueras M, Olivella L, Tirapu L, Vilanova M, Barcelo D. 2001. Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: Methods and preliminary results including toxicity studies with Vibrio fischeri. J Chromatogr A 938:187-197.
8. Lee RB, Sarafin K, Peart TE, Svoboda ML. 2003. Acidic pharmaceuticals in sewage - Methodology, stability test, occurrence, and removal from Ontario samples. Water Qual Res J Can 38: 667-682.
9. Paje MLF, Kuhlicke U, Winkler M, Neu TR. 2002. Inhibition of lotic biofilms by diclofenac. Appi Microbiol Biotechnol 59:488-494.
10. Ferrari B, Paxeus N, Lo Guidice R, Pollio A, Garric J. 2003. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: Study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol Environ Saf 55:359-370.
11. Chénier MR, Beaumier D, Roy R, Driscoll BT, Lawrence JR, Greer CW. 2003. Impact of seasonal variations and nutrient inputs on the cycling of nitrogen and the degradation of hexadecane by replicated river biofilms. Appl Environ Microbiol 69:5170-5177.
12. Chénier MR, Beaumier D, Fortin N, Roy R, Driscoll BT, Lawrence JR, Greer CW. 2006. Influence of nutrient inputs, hexadecane, and temporal variations on denitrification and community composition of river biofilms. Appl Environ Microbiol 72:575-584.
13. Lawrence JR, Chénier M, Roy R, Beaumier D, Fortin N, Swerhone GDW, Neu TR, Greer CW. 2004. Microscale and molecular assessment of the impacts of nickel, nutrients, and oxygen level on river biofilm communities. Appl Environ Microbiol 70:4326-4339.
14. Lawrence JR, Swerhone GDW, Wassenaar LI, Neu TR. 2005. Effects of selected pharmaceuticals on riverine biofilm communities. Can J Microbiol 51:655-669.
15. Neu TR, Wölfl S, Lawrence JR. 2004. 3-dimensional differentiation of phototrophic biofilm constituents by multi channel confocal and 2-photon laser scanning microscopy: J Microbiol Methods 56:161-172.
16. Neu TR, Swerhone GDW, Lawrence JR. 2001. Assessment of lectin-binding analysis for in situ detection of glycoconjugates in biofilm systems. Microbiology 147:299-313.
17. Nour SM, Lawrence JR, Zhu H, Swerhone GDW, Welsh M, Welacky T, Topp E. 2003. Bacteria associated with cysts of the soybean cyst nematode (Heterodera glycines). Appl Environ Microbiol 69:607-615.
18. Manz W, Wendt-Potthoff K, Neu TR, Szewzyk U, Lawrence JR. 1999. Phylogenetic composition, spatial structure, and dynamics of lotic bacterial biofilms investigated by fluorescent in situ hybridization and confocal scanning laser microscopy. Microb Ecol 37:225-237.
19. 3H]thymidine macromolecular incorporation and lipid labeling: Their significance to DNA labeling during measurements of aquatic bacterial growth rate. Limnol Oceanogr 34:213-222.
20. Packroff G, Lawrence JR, Neu TR. 2002. In situ confocal laser scanning microscopy of protozoans in pure cultures and complex communities. Acta Protozool 41:245-253.
21. Teece MA, Vogel ML. 2004. Preparation of ecological and biochemical samples for isotope analysis. In de Groot PA, ed, Handbook of Stable isotope Analytical Techniques. Elsevier, Amsterdam, The Netherlands, pp 177-202.
22. Verhaar HJM, Van Leeuwen CJ, Hermens JLM. 1992. Classifying environmental pollutants. 1. Structure-activity relationships for prediction of aquatic toxicity. Chemosphere 25:471-491.
23. Dastidar SG, Ganguly K, Chaudhuri K, Chakrabarty AN. 2000. The antibacterial action of diclofenac shown by inhibition of DNA-synthesis. Int J Antimicrob Agents 14:49-251.
24. Cleuvers M. 2003. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142: 185-194.
25. Jones OAH, Voulvoulis N, Lester JN. 2002. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res 36:5013-5022.
26. Ferrari B, Mons R, Vollat D, Fraysse B, Paxeus N, LoGiudice R, Pollio A, Garric J. 2004. Environmental risk assessment of six human pharmaceuticals: Are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Toxicol Chem 23:1344-1354.
27. Baath E, DiAz-Ravin M, Frostegard AA, Campell CD. 1998. Effect of metal-rich sludge amendments on the soil microbial community. Appl Environ Microbiol 64:238-245.
28. Perilli R, Marziano ML, Formisano G, Caiazza S, Scorcia G. 2000. Alteration of organized structure of biofilm formed by Staphylococcus epidermidis on soft contact lenses. J Biomed Mater Res 49:53-57.
29. Mohamed MN, Lawrence JR, Robarts RD. 1998. Phosphorus limitation of heterotrophic biofilms from the Fraser River, British Columbia, and the effect of pulp mill effluent. Microb Ecol 36: 121-130.
30. Neu TR, Swerhone GDW, Bockelmann U, Lawrence JR. 2005. Effect of carbon, nitrogen, and phosphorus on the nature and development of lectin-specific glycoconjugates in lotic biofilms. Aquat Microb Ecol 38:283-294.
31. Brümmer HM, Fehr W, Wagner-Döbler I. 2000. Biofilm community structure in polluted rivers: Abundance of dominant phylogenetic groups over a complete annual cycle. Appl Environ Microbiol 66:3078-3082.
32. Niederlehner BR, Cairns J Jr. 1992. Community response to cumulative toxic impact: Effects of acclimation on zinc tolerance of Aufwuchs. Can J Fish Aquat Sci 49:2155-2163.
33. Zwiener C, Frimmel FH. 2000. Oxidative treatment of pharmaceuticals in water. Water Res 34:1881-1885.
34. Ternes TA. 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245-3260.
35. Andreozzi R, Raffaele M, Nicklas P. 2003. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50:1319-1330.
36. Webster R, Pacey M, Winchester T, Johnson P, Jezequel S. 1998. Microbial oxidative metabolism of diclofenac: Production of 4′-hydroxy diclofenac using Epiccocum nigrum IMI354292. Appl Microbiol Biotechnol 49:371-376.
37. Bort R, Mace K, Boobis A, Gomez-Lechon MJ, Pfeifer A, Castell J. 1999. Hepatic metabolism of diclofenac: Role of human CYP in the minor oxidative pathways. Biochem Pharmacol 58:787-796.
38. Quintana JB, Weiss S, Reemtsma T. 2005. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res 39:2654-2664.